Iterum Therapeutics plc — Director's Dealing 2021

Jun 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2021-06-23

Reporting Person: Fishman Corey N. (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-23	Stock Option (Right to Buy)	$2.01	A	5280000	Acquired	2031-06-22	Ordinary Shares (5280000)	Direct

Footnotes

F1: The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 23, 2021 and the remaining 75% will vest in equal monthly installments thereafter until June 23, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.